Outcomes, Access, and Cost Issues Involving PCSK9 Inhibitors to Lower LDL-Cholesterol Thomas F. Whayne Current Opinion 02 February 2018 Pages: 287 - 291
Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy Hannah K. ShorrockThomas H. GillingwaterEwout J. N. Groen Leading Article Open access 29 January 2018 Pages: 293 - 305
Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults Martin Holtkamp Review Article 24 January 2018 Pages: 307 - 326
Efficacy and Safety of Tiotropium in Children and Adolescents Eckard HamelmannStanley J. Szefler Review Article Open access 24 January 2018 Pages: 327 - 338
Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review Arnaud SteyaertPatricia Lavand’homme Review Article 29 January 2018 Pages: 339 - 354
Belimumab: A Review in Systemic Lupus Erythematosus Hannah A. BlairSean T. Duggan Adis Drug Evaluation 02 February 2018 Pages: 355 - 366
Eculizumab: A Review in Generalized Myasthenia Gravis Sohita Dhillon Adis Drug Evaluation Open access 12 February 2018 Pages: 367 - 376
Landiolol: A Review in Tachyarrhythmias Yahiya Y. Syed Adis Drug Evaluation 22 February 2018 Pages: 377 - 388
Netarsudil Ophthalmic Solution 0.02%: First Global Approval Sheridan M. Hoy AdisInsight Report 16 February 2018 Pages: 389 - 396
Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma Hannah A. Blair Correction 24 January 2018 Pages: 397 - 397